Cardiovascular outcomes with icosapent ethyl by burden of standard modifiable cardiovascular risk factors in REDUCE-IT

By afschroeder • April 21, 2026

Aggarwal R, Bhatt DL, Miller M, Ballantyne CM, Brinton EA, Jacobson TA, Ketchum SB, Tardif JC, Budoff MJ, Figtree GA, Steg PG; REDUCE-IT Investigators. Cardiovascular outcomes with icosapent ethyl by burden of standard modifiable cardiovascular risk factors in REDUCE-IT. Am J Prev Cardiol. 2026 Feb 2;26:101458. doi: 10.1016/j.ajpc.2026.101458. PMID: 42006413; PMCID: PMC13084092.

Tags: Cardiology/Epi, Cardiovascular, Harbor UCLA, Icosapent ethyl, Publications, standard modifiable cardiovascular risk factors

Predictors of bleeding-related in-hospital complications after coronary angiography and percutaneous coronary intervention: A single-center retrospective cohort study in Iran

Andishmand A, Soltani MH, Mohammadi H, Namayandeh SM, Peigan P, Budoff M, Azimizadeh M, Andishmand M, Andishmand M. Predictors of bleeding-related in-hospital complications after coronary[...]

Cannabis Exposure After Pregnancy and Development of Hypertension in the nuMoM2b Heart Health Study

Dahl CM, Chahine R, Wiener LE, Silver RM, McMillin GA, Catov JM, Chung J, Greenland P, Grobman WA, Hoffman M, Khan SS, Levine L, Pippen[...]

Successful Heart Transplantation in a Patient with Sporadic Inclusion Body Myositis-A Case Report

Kumar A, Okwuosa I, Vellanki S, Kamath M. Successful Heart Transplantation in a Patient with Sporadic Inclusion Body Myositis-A Case Report. CJC Open. 2025 Dec[...]